Sinocelltech Group Limited

Shanghai Stock Exchange 688520.SS

Sinocelltech Group Limited Revenue Per Share for the year ending December 31, 2023: USD 0.60

Sinocelltech Group Limited Revenue Per Share is USD 0.60 for the year ending December 31, 2023, a 75.73% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Sinocelltech Group Limited Revenue Per Share for the year ending December 31, 2022 was USD 0.34, a 599.73% change year over year.
Sinocelltech Group Limited Revenue Per Share for the year ending December 31, 2021 was USD 0.05, a 41,970.20% change year over year.
Sinocelltech Group Limited Revenue Per Share for the year ending December 31, 2020 was USD 0.00, a -86.73% change year over year.
Sinocelltech Group Limited Revenue Per Share for the year ending December 31, 2019 was USD 0.00, a -22.74% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

Shanghai Stock Exchange: 688520.SS

Sinocelltech Group Limited

CEO	Dr. Liangzhi Xie Ph.D.
IPO Date	June 22, 2020
Location	China
Headquarters	No. 31 Kechuang 7th Street
Employees	2,313
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Sinocelltech Group Limited, a biotech company, focuses on the development of technologies for the development and manufacturing of recombinant proteins, monoclonal antibodies, and vaccines in China. The company is based in Beijing, China.

Key trends

Past 5 years